#HVO hVIVO PLC – Final Results April 10, 2025 – Posted in: Uncategorized

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (“CRO”) and the world leader in human challenge clinical trials, announces its audited results for the year ended 31 December 2024.   Financial highlights • Revenue up 11.9% to £62.7 million (2023: £56.0 million) • EBITDA up 25.9% to £16.4 million (2023: £13.0 million) • EBITDA margin of 26.2% (2023: 23.3%) • Underlying EBITDA of £13.4 million (23.0%) excluding the Canary Wharf facility fee and overlapping…

Continue reading